Back to ABN AMRO Bank N.V. ABN AMRO Bank N.V.

TEVATEVA

Showing 4 of 10 quarters

Position history for ABN AMRO Bank N.V.ABN AMRO Bank N.V.'s holdings in Teva Pharmaceutical Industries Limited

No. ABN AMRO Bank exited its TEVA (Teva Pharmaceutical Industries) position in Q2 2025. Its Q1 2025 13F listed 18,300 shares worth $281,024. ABN AMRO Bank already held TEVA in its Q1 2023 13F, the earliest on record, and held it in 9 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$328,067

Total Shares Change

-18,300

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q2
Latest
Exited
0
-100.0%
$00.0%$16.76
0
2025-Q1
Unchanged
18,300
0.0%
$281,0240.0%$15.37
0
2024-Q4
Unchanged
18,300
0.0%
$398,9170.0%$22.04
0
2024-Q3
Unchanged
18,300
0.0%
$328,0670.0%$18.02
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used